Bonducellin exhibits significant antimicrobial activity, particularly against Gram-positive bacteria, making it a candidate for development in antibacterial agents. It has also shown antifungal properties, which may be useful in treating fungal infections or preserving materials prone to microbial degradation. Additionally, bonducellin demonstrates anti-inflammatory effects, suggesting potential use in pharmaceuticals targeting inflammatory diseases. Its natural origin and bioactivity profile support further investigation for therapeutic applications, especially in designing novel drugs with improved efficacy and reduced resistance development.